Completed Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependents (Texas)

Study of Safety and Potential Efficacy of SYN117 in Cocaine Dependent Volunteers

This study will assess the potential interaction and subjective effects between intravenous cocaine and SYN117 in non-treatment seeking cocaine dependant subjects

http://en.wikipedia.org/wiki/Nepicastat

SYN117 prevents the conversion of dopamine to norepinephrine by inhibiting dopamine beta-hydroxylase.

Estimated Enrollment: 16
Study Start Date: June 2008
Estimated Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)

Contacts
Contact: Crystal Carbone 409-392-3647 [email protected]
Contact: Kathryn Cunningham, PhD 409-772-9640 [email protected]

United States, Texas
University of Texas Medical Branch (UTMB)
Galveston, Texas, United States, 77555

http://www.clinicaltrials.gov/ct2/show/NCT00656357

This study is now complete although no publications yet to be submitted to the NIH.